Cite

HARVARD Citation

    Schmitz, R. et al. (n.d.). The successful patient-preference design for the LORD-trial to test whether active surveillance for low-risk Ductal Carcinoma In Situ is safe. European journal of cancer. pp. S3-S4. [Online]. 
  
Back to record